Comments on a study on the benefits of early invasive management strategy in women with acute coronary syndromes (ACS). Efficacy of an early invasive strategy in ACS; Meta-analysis of glycoprotein IIb/IIIa agents in ACS; Clinical trials that are needed to find out if women benefit from early revascularization in ACS.